Home
About Us
Contact Us
Overview
Organization
Progress Report
State of the Science Symposium
Protocols
Protocols
Affiliate Center Application
New Study Form
Bidders
Links
BMT CTN SharePoint
BMT CTN AdvantageEDC
NHLBI Resources
NHLBI Website
National MDS Study
PACT (cellular)
GTRP (vectors)
SMARTT (biologics)
NCI
NMDP Patient Info
CIBMTR
CTSU
Jason Carter Clinical Trials Program
Clinical Trials.gov
NCI IRB Page
Emmes
Resources
Manual of Procedures
Definitions
Video Clips
IFI Cost Calculator
Research Material
Biospecimen Collections
Data for Secondary Analyses
Case Report Forms
Reports
BMT CTN Funding Opportunity & RFI
RFA-HL-19-027: Catalyzing Innovation in Late Phase Clinical Trial Design and Statisical Analysis Plans (U34 Clinical Trial Not Allowed)
PAR-18-768: Catalyzing Innovation in Late Phase Clinical Trial Design and Statisical Analysis Plans Resource Access (X01 Clinical Trial Not Allowed)
RFA-HL-17-22: Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)
Funding Opportunity Announcement for NHLBI Clinical Ancillary Studies (R01)
Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
BMT CTN Publications
Publications
BMT CTN News
Core Clinical Centers/Consortia of the BMT CTN for July 2017 - June 2024
Newly Added Protocols
BMTCTN 1601
BMTCTN 1507
BMTCTN 1506
Definitions
Below are definitions used on BMT CTN trials:
Definitions of Chronic Graft-vs.-Host Disease (GVHD)
Severity Grading Table and Recurrence Interval Definitions
Definitions of Infection Severity
Common Terminology Criteria for Adverse Events (CTCAE) v3.0
Common Terminology Criteria for Adverse Events (CTCAE) v4.0
Social Media
